Skip to Main Content

Paper Details

Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models.
Haematologica
75
2021
Author NameAffiliation
Neil P ShahHelen Diller Comprehensive Cancer Center, University of California at San Francisco
Elisabeth A LasaterInc.
  • 1 - 2

Datasets

Release 1.2